VoluMetrix
PrivateLast Round
Accelerator
Feb 26, 2026
Total Funding Raised
$5.99M
Company Overview
VoluMetrix is a biotechnology company that develops non-invasive vital monitoring technology, including its flagship NIVAHF device for heart failure patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VoluMetrix Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
VoluMetrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 26, 2026 | ||||
| Grant | May 30, 2023 | ||||
| Grant | Apr 30, 2023 | ||||
| Grant | Jun 15, 2021 | ||||
| Grant | Oct 30, 2020 |
Key People
Founding team and executive leadership
VoluMetrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nashville Entrepreneur Center | Accelerator |
| NIH RADx | Grant |
| Tennessee Technology Development Corporation | Grant |
| BioFlorida, Inc. | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Food and Drug Administration | Grant |
| Pennsylvania Pediatric Medical Device Consortium | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2023
Secured $3M from National Heart, Lung, and Blood Institute and NIH RADx.
VoluMetrix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VoluMetrix's valuation, stock price, and market status.